Overview
The DIA Cell and Gene Therapy Summit — “Pioneering Precision: Cell and Gene Therapy Development and Innovation” will gather Korea’s scientific, regulatory, and industry leaders with global experts to discuss how precision medicine is shaping the future of Cell and Gene Therapy development. As a rapidly emerging contributor to global innovation, Korea offers world-class research, advanced clinical infrastructure, and strong policy support for biopharmaceutical development. The Summit will serve as a platform to explore strategies for accelerating clinical translation, strengthening regulatory science, and expanding patient access to innovative therapies through collaboration across science, regulation, and industry.
Featured
Want to learn more about DIA Korea Cell and Gene Therapy Summit? You've come to the right site!
Program Committee
-
Yil-Seob Lee, MD, PhD Professor
CHA Bundang Medical Center , Korea, Republic of -
Youngju Choi, PhD Director General of Biopharmaceutical & Herbal Medicine Evaluation Department
National Institute of Food & Drug Safety (NIFDS), Korea, Republic of -
So Ra Park President
Regenerative Medicine Acceleration Foundation, Korea, Republic of -
Jungtae Park Vice Chairman
Korea Biomedicine Industry Association, Korea, Republic of -
Meehyun Jung Executive Director
CTX, Inc., Korea, Republic of -
In-sook Park, PhD Director General
Korean Regulatory Science Center, Korea, Republic of -
Hye Ryun Esther Bahng, MSc Senior Director of Market Access and Regulatory Affairs
Market Access & Regulatory Affairs, Astrazeneca, Korea, Republic of -
MinYoung Kim Professor
CHA University School of Medicine , Korea, Republic of -
Young Joo Park, PhD, MPH VP, Korea, Singapore, and Southeast Asia
DIA, Korea, Republic of
Have an account?